LAUREN VREE: Open Payments
NPI 1760701247 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $168 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $152 |
| Merck Sharp & Dohme LLC | 5 | $138 |
| Novo Nordisk Inc | 2 | $51 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Theratechnologies Inc. | 1 | $17 |
Products named: PIFELTRO, RUKOBIA, APRETUDE, REXULTI, JARDIANCE, Wegovy, SHINGRIX, GARDASIL 9.
Industry payments across CA — which companies pay providers there.
